|
1
|
Berka K, Hendrychová T, Anzenbacher P and
Otyepka M: Membrane position of ibuprofen agrees with suggested
access path entrance to cytochrome P450 2C9 active site. J Phys
Chem A. 115:11248–11255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas JH: Rapid birth-death evolution
specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS
Genet. 3:e672007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guengerich FP: Cytochrome p450 and
chemical toxicology. Chem Res Toxicol. 21:70–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Genome Atlas Research Network.
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H,
Robertson AG, Pashtan I, Shen R, Benz CC, et al: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adzhubei I, Jordan DM and Sunyaev SR:
Predicting functional effect of human missense mutations using
PolyPhen-2. Curr Protoc Hum Genet Chapter. 7:Unit7.202013.
|
|
6
|
Kanehisa M, Golo S, Hattori M,
Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M and
Hirakawa M: From genomics to chemical genomics: New developments in
KEGG. Nucleic Acids Res. 34:D354–D357. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanukoglu I: Steroidogenic enzymes:
Structure, function, and role in regulation of steroid hormone
biosynthesis. J Steroid Biochem Mol Biol. 43:779–804. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Payne AH and Hales DB: Overview of
steroidogenic enzymes in the pathway from cholesterol to active
steroid hormones. Endocr Rev. 25:947–970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moon JY, Moon MH, Kim KT, Jeong DH, Kim
YN, Chung BC and Choi MH: Cytochrome P450-mediated metabolic
alterations in preeclampsia evaluated by quantitative steroid
signatures. J Steroid Biochem Mol Biol. 139:182–191. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Helmberg A: Twin genes and endocrine
disease: CYP21 and CYP11B genes. Acta Endocrinol (Copenh).
129:97–108. 1993.PubMed/NCBI
|
|
11
|
Stowasser M, Gunasekera TG and Gordon RD:
Familial varieties of primary aldosteronism. Clin Exp Pharmacol
Physiol. 28:1087–1090. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alvarez-Madrazo S, Mackenzie SM, Davies E,
et al: Common polymorphisms in the CYP11B1 and CYP11B2 genes:
Evidence for a digenic influence on hypertension. Hypertension.
61:232–239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Padmanabhan N, Padmanabhan S and Connell
JM: Genetic basis of cardiovascular disease - the
renin-angiotensin-aldosterone system as a paradigm. J Renin
Angiotensin Aldosterone Syst. 1:316–324. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davis RA, Miyake JH, Hui TY and Spann NJ:
Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.
J Lipid Res. 43:533–543. 2002.PubMed/NCBI
|
|
15
|
Marx CE, Bradford DW, Hamer RM, Naylor JC,
Allen TB, Lieberman JA, Strauss JL and Kilts JD: Pregnenolone as a
novel therapeutic candidate in schizophrenia: Emerging preclinical
and clinical evidence. Neuroscience. 191:78–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hoehn K and Marieb EN: The endocrine
system. Human Anatomy & Physiology (8th). Benjamin Cummings.
(San Francisco, CA). 606–612. 2010.
|
|
17
|
Chyun YS, Kream BE and Raisz LG: Cortisol
decreases bone formation by inhibiting periosteal cell
proliferation. Endocrinology. 114:477–480. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu C, Rusin CG, Tan Z, Guagliardo NA and
Barrett PQ: Zona glomerulosa cells of the mouse adrenal cortex are
intrinsic electrical oscillators. J Clin Invest. 122:2046–2053.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Claus EB, Risch N and Thompson WD: Genetic
analysis of breast cancer in the cancer and steroid hormone study.
Am J Hum Genet. 48:232–242. 1991.PubMed/NCBI
|
|
20
|
He Q, Liang CH and Lippard SJ: Steroid
hormones induce HMG1 overexpression and sensitize breast cancer
cells to cisplatin and carboplatin. Proc Natl Acad Sci USA.
97:5768–5772. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Colleoni M, Viale G, Zahrieh D, et al:
Chemotherapy is more effective in patients with breast cancer not
expressing steroid hormone receptors: A study of preoperative
treatment. Clin Cancer Res. 10:6622–6628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eliassen AH, Missmer SA, Tworoger SS,
Spiegelman D, Barbieri RL, Dowsett M and Hankinson SE: Endogenous
steroid hormone concentrations and risk of breast cancer among
premenopausal women. J Natl Cancer Inst. 98:1406–1415. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Platz EA, Leitzmann MF, Rifai N, Kantoff
PW, Chen YC, Stampfer MJ, Willett WC and Giovannucci E: Sex steroid
hormones and the androgen receptor gene CAG repeat and subsequent
risk of prostate cancer in the prostate-specific antigen era.
Cancer Epidemiol Biomarkers Prev. 14:1262–1269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaiser U, Hofmann J, Schilli M, Wegmann B,
Klotz U, Wedel S, Virmani AK, Wollmer E, Branscheid D, Gazdar AF
and Havemann K: Steroid-hormone receptors in cell lines and tumor
biopsies of human lung cancer. Int J Cancer. 67:357–364. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Potischman N, Hoover RN, Brinton LA,
Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB,
Barrett RJ, et al: Case-control study of endogenous steroid
hormones and endometrial cancer. J Natl Cancer Inst. 88:1127–1135.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lointier P, Wildrick DM and Boman BM: The
effects of steroid hormones on a human colon cancer cell line in
vitro. Anticancer Res. 12:1327–1330. 1992.PubMed/NCBI
|
|
27
|
De Maria N, Manno M and Villa E: Sex
hormones and liver cancer. Mol Cell Endocrinol. 193:59–63. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu S, Kounenidakis M, Schmidt EM,
Deshpande D, Alkahtani S, Alarifi S, Föller M, Alevizopoulos K,
Lang F and Stournaras C: Rapid activation of
FAK/mTOR/p70S6K/PAK1-signaling controls the early
testosterone-induced actin reorganization in colon cancer cells.
Cell Signal. 25:66–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koehler KF, Helguero LA, Haldosén LA,
Warner M and Gustafsson JA: Reflections on the discovery and
significance of estrogen receptor beta. Endocr Rev. 26:465–478.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patrone C, Cassel TN, Pettersson K, Piao
YS, Cheng G, Ciana P, Maggi A, Warner M, Gustafsson JA and Nord M:
Regulation of postnatal lung development and homeostasis by
estrogen receptor beta. Mol Cell Biol. 23:8542–8552. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bardin A, Boulle N, Lazennec G, Vignon F
and Pujol P: Loss of ERbeta expression as a common step in
estrogen-dependent tumor progression. Endocr Relat Cancer.
11:537–551. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bouchardy C, Benhamou S, Schaffar R,
Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria JC,
Vlastos G and Rapiti E: Lung cancer mortality risk among breast
cancer patients treated with anti-estrogens. Cancer. 117:1288–1295.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kazmi N, Márquez-Garbán DC, Aivazyan L,
Hamilton N, Garon EB, Goodglick L and Pietras RJ: The role of
estrogen, progesterone and aromatase in human non-small-cell lung
cancer. Lung Cancer Manag. 1:259–272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Bono JS, Logothetis CJ, Molina A,
Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F,
et al: COU-AA-301 Investigators: Abiraterone and increased
survival in metastatic prostate cancer. N Engl J Med.
364:1995–2005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JJ, Kurita T and Bulun SE:
Progesterone action in endometrial cancer, endometriosis, uterine
fibroids, and breast cancer. Endocr Rev. 34:130–162. 2013.
View Article : Google Scholar : PubMed/NCBI
|
